DOCSLIB.ORG

Innovate for Collective Impact to End Malaria

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Innovate for Collective Impact to End Malaria Innovate for Collective Impact to End Malaria East Court/Lecture Rooms National Academy of Sciences Washington, D.C. USA January 11, 2019 Foreword For the second consecutive year, the World Health Organization (WHO) 2018 World Malaria Report confirms that global efforts to fight malaria have hit a plateau. Although there have been pockets of progress, the truth is that, at the global level, the great achievements of the past 20 years have stalled, and the world is still far from reaching the 2020 targets. Recognizing that we need to do things in a different manner, the WHO and the RBM Partnership to End Malaria launched the “High burden to high impact: a targeted malaria response” strategy, a country- focused and -led plan to support countries with high disease burden. However, greater efforts from the global health community will be needed if we want to achieve the goal of eradicating malaria once and for all. Research and development for malaria is paramount at this stage. We need to tightly integrate evidence- based decision-making, problem-solving, and innovation into the creation of effective new tools and strategies that replace—or complement—those currently in use. In addition, we also need to achieve the financial stability that guarantees continuity of the fight against malaria, including making a clear and definitive case for the economic benefits of malaria reduction and elimination to relevant stakeholders. Now more than ever, partnerships across sectors will be a critical element toward progress against this age-old scourge. Therefore, today’s gathering of actors from diverse sectors of the global health community—including academia, civil society/nonprofit organizations, and local National Malaria Programs—is an excellent starting point to identify the barriers that have led us to the current situation, and to define the best way forward in the fight against malaria. As General Director of the Barcelona Institute for Global Health (ISGlobal)—a WHO Collaborating Centre in Malaria Control, Elimination, and Eradication since 2013—I am delighted to welcome you to the “Innovate for Collective Impact to End Malaria” Symposium. Today’s event is sponsored by the Malaria Eradication Scientific Alliance (MESA Alliance) in partnership with the Harvard T.H. Chan School of Public Health and organized in collaboration with the American Society of Tropical Medicine and Hygiene; Barcelona Institute for Global Health (ISGlobal), Friends of the Global Fight to Fight Against AIDS, Tuberculosis, and Malaria; Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative; and the U.S. National Institute of Allergy and Infectious Diseases. Sincerely, Antoni Plasència, MD, MPH, PhD Director General Barcelona Institute for Global Health 3 Background After a significant decline in malaria cases and deaths over the past decade, estimates from the World Health Organization (WHO) flagship malaria publication—2018 World Malaria Report—point to a stall in the progress over the past two years. Whereas the estimated people with malaria steadily fell from 239 million in 2010 to 214 million in 2015, an estimated 219 million cases of malaria were reported in 2017. At the same time, 46 countries have fewer than 10,000 cases, and of these, 21 countries are targeting elimination of malaria transmission by 2020. The global plateau in malaria morbidity and mortality contrasts with the significant progress towards elimination in a number of countries. This sobering new data is a stark reminder that innovation—from biomedical research and the adaptation of technical solutions/tools for local contexts to narrowing global finance gaps—will be a critical element to both sustaining the gains achieved over the past ten years and advancing the goal of eradication. In addition to current efforts to shore up financial and political support for the Global Fund to Fight for AIDS, TB, and Malaria, the global malaria community will need to explore new opportunities for innovative financing (e.g., new country-level investments from governments in malaria endemic countries, expanded engagement with the private sector, philanthropy, and civil society in all countries, and cross sectoral collaborations) for long-term success to combat malaria. At a critical time in the fight against malaria, a global gathering of key stakeholders will participate in the 2019 “Innovate for Collective Impact to End Malaria” meeting. Together, we will discuss and prioritize findings from the 2018 World Malaria Report and develop innovative approaches to collective bridge issues in malaria eradication spanning research, financing, and implementation. This dialog will consider the diversity of challenges across countries as well as the opportunities afforded by socioeconomic development, improved communication systems, and most importantly, the aspirations of the countries themselves. This meeting is sponsored by the Malaria Eradication Scientific Alliance (MESA Alliance) and the Harvard T.H. Chan School of Public Health, and organized in collaboration with the American Society of Tropical Medicine and Hygiene; Barcelona Institute for Global Health (ISGlobal), Friends of the Global Fight to Fight Against AIDS, Tuberculosis, and Malaria; Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative; and the U.S. National Institute of Allergy and Infectious Diseases. 4 About Malaria Eradication Scientific Alliance The mission of the MESA Alliance is based on the core principles of driving scientific rigor, accelerating innovation, expanding inclusiveness, ensuring transparency, and cultivating agility. The MESA Alliance supports the global malaria community by providing a dedicated platform to drive an evidence-based approach to global malaria eradication; creating knowledge management tools to accelerate and expand the impact of the relevant evidence base; and accelerating research, especially in areas relevant for policy makers and programmes. The MESA Alliance is supported by a grant from the Bill & Melinda Gates Foundation, and is hosted by the Barcelona Institute for Global Health (ISGlobal), which is a World Health Organization (WHO) Collaborating Centre for Malaria Control, Elimination, and Eradication. About Harvard T.H. Chan School of Public Health and Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative Harvard T.H. Chan School of Public Health traces its roots to public health activism at the beginning of the last century, a time of energetic social reform. From the start, faculty were expected to commit themselves to research as well as teaching. The Harvard Chan brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. The Harvard Chan—and the wider university—has had a long history of pursuing and advancing malaria research, education, and leadership development. More recently, the university formally established the Defeating Malaria: From the Genes to the Globe Initiative—a cross-school effort to produce, transmit, and translate knowledge to support the control and ultimate eradication of malaria. Through this faculty-led initiative, Harvard contributes to bridging intellectual and operational gaps in malaria research, knowledge, and training to create sustained, real world impact. Harvard’s Defeating Malaria Initiative is centered on fostering multidisciplinary collaboration on global challenges, establishing new types of external partnerships, and serving as an inspiration and rallying cry for others to join the fight. 5 Meeting agenda 8:00AM Registration & Coffee (East Court Room) Welcome & Opening Remarks 8:30AM Speaker: Regina Rabinovich, MD, MPH, Director, Malaria Eradication Scientific (Lecture Room) Alliance, Barcelona Institute for Global Health (ISGlobal); ExxonMobil Malaria Scholar in Residence at Harvard University Opening Session: Mapping the Trajectory—Implications of the 2018 World Malaria Report Introduction: Chandy C. John, MS, MD, FASTMH, Ryan White Endowed Chair in 9:00AM Pediatric Infectious Diseases, Indiana University Speaker (via video conference): Pedro L. Alonso, MD, PhD, Director, Global Malaria Program, World Health Organization (WHO) Panel Session: Overcoming Finance Obstacles for Sustainability Session Chair: Alan Court, MSc, Special Advisor, WHO Ambassador for Global Strategy Panelists: 9:40AM Olusoji Adeyi, MD, MBA, DrPH, Director, Health, Nutrition, and Population Global Practice, World Bank Group Mark Dybul, MD, Professor of Medicine and Faculty Co-Director, Center for Global Health and Quality, Georgetown University Medical Center 10:15AM Break (East Court Room) Panel Session: Resistance as a Driver for Innovation Session Chair: Lee Hall, MD, PhD, Chief, Parasitology and International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases Panelists: Abdoulaye Djimdé, PhD, Associate Professor of Microbiology and 10:30AM Immunology, Chief of the Molecular Epidemiology and Drug Resistance Unit, University of Bamako David A. Fidock, PhD, Professor of Microbiology & Immunology and of Medical Sciences, Columbia University Medical Center Christen Fornadel, PhD, Technical Coordinator, IVCC Carol Sibley, PhD, Professor of Genome Sciences, University of Washington and Founder and Senior Scientific Advisor, WorldWide Antimalarial Resistance Network Keynote Address Introduction: Rose Leke, PhD,
Load more

Recommended publications
  • Evelyn Ansah Tom Burkot
    Malaria Elimination Oversight Committee Panel members’ biographies Evelyn Ansah Dr Evelyn Korkor Ansah is an Associate Professor of Clinical Epidemiology and Director of the Centre for Malaria Research, University of Health and Allied Sciences in Ghana. Prior to this, she was the Deputy Director responsible for Research at the Research & Development Division of the Ghana Health Service. Her basic training was in Medicine at the School of Medical Sciences, Kwame Nkrumah University of Science and Technology in Ghana. She later pursued a Master of Public Health at the School of Public Health, University of Ghana and subsequently a PhD in Epidemiology at the London School of Hygiene and Tropical Medicine, University of London. She was admitted as a Fellow of the Ghana College of Physicians and Surgeons in 2009. Dr Ansah has worked at all levels of the health system. She practised as a doctor for three years at the Ridge Regional Hospital, Ghana. Following this, she worked as a District Medical Officer in a rural area in Ghana for an initial eight years and became District Director of Health Service for seven years. As Deputy Director of the Research & Development Division of the Ghana Health Service she was responsible for coordination of the Ghana Health Service National Research Agenda as well as research capacity strengthening. Her research interests lie in malaria, diagnostics, health systems, public health and capacity building for health research. She serves as a reviewer and has several publications in peer-reviewed journals. She serves as a member of various committees (i.e. Steering Committee of the ACT Consortium and as an investigator of the Malaria Capacity Development Consortium) and is the founding Chair of the Institutional Review Board of the Dodowa Health Research Centre, Ghana.
    [Show full text]
  • High-Level Launch Event for the Second EDCTP Programme Proceedings
    High-level launch event for the second EDCTP programme Strengthening the partnership for fighting poverty-related diseases in Africa Proceedings 2 December 2014 Cape Town, South Africa Towards the second EDCTP programme The EDCTP high-level launch event for the EDCTP was created in 2003 as a European second EDCTP programme is the last meet- response to the global health crisis caused by ing in a series of high-level meetings planned the three main poverty-related diseases (PRDs) to contribute to the shaping of the strategy of HIV/AIDS, tuberculosis and malaria. Under and funding approach of the second EDCTP its first programme EDCTP is a partnership programme. These proceedings document the between 16 European countries, the European third high-level meeting dedicated to establish- Union and sub-Saharan African countries. ing the second EDCTP programme. The first The second programme under the European meeting took place in Cape Town, South Africa research framework programme Horizon 2020 on 5 November 2012 and the second meeting is implemented by EDCTP as a partnership of 13 was in Dakar, Senegal, on 21 October 2013. European and 13 African countries that govern EDCTP as members of the EDCTP Association. The EDCTP stakeholder and high-level meetings The aim of the programme remains to acceler- were supported by the European Union through ate the development of new or improved drugs, a Seventh Framework Programme (FP7) grant vaccines, microbicides and diagnostics for for the Coordination and Support Action project HIV/AIDS, tuberculosis and malaria as well as EDCTP-Plus (FP7-304786) as part of the prepa- neglected and emerging infectious diseases in rations for the second phase of the EDCTP collaboration with the pharmaceutical industry programme.
    [Show full text]
  • Certification of Polio Eradication: Process and Lessons Learned Sir Joseph Smith,1 Rose Leke,2 Anthony Adams,3 & Rudolf H
    Certification of polio eradication: process and lessons learned Sir Joseph Smith,1 Rose Leke,2 Anthony Adams,3 & Rudolf H. Tangermann4 Abstract Since the 1988 World Health Assembly resolution to eradicate poliomyelitis, considerable progress has been made towards interrupting the transmission of wild poliovirus globally. A formal process for the certification of polio eradication was established on the basis of experience gained during smallpox eradication. Independent groups of experts were designated at the global, regional, and country levels to conduct the process. The main requirements for the global certification of the eradication of wild poliovirus are the absence of wild poliovirus, isolated from suspect polio cases, healthy individuals, or environmental samples, in all WHO regions for a period of at least three years in the presence of high-quality, certification-standard surveillance and the containment of all wild poliovirus stocks in laboratories. Three WHO regions — the Region of the Americas (1994), Western Pacific Region (2000), and European Region (2002) — have already been certified free of indigenous wild poliovirus. Eradication and certification activities are progressing well in the three endemic regions (African, Eastern Mediterranean, and South-East Asia). Several challenges remain for the certification of polio eradication: the need for even closer coordination of certification activities between WHO regions, the verification of laboratory containment, the development of an appropriate mechanism to verify the absence of circulating vaccine-derived polioviruses in the future, and the maintenance of polio-free status in certified regions until global certification. Keywords Poliomyelitis/prevention and control/diagnosis; Certification/organization and administration/standards/trends; Poliovirus/growth and development; Paralysis/etiology; Epidemiologic surveillance; Containment of biohazards; World Health Organization (source: MeSH, NLM).
    [Show full text]
  • Mindset Shift for Ownership of Our Continent's Development
    Cover Photo Credits: (Clockwise from top right): Child outside of medical clinic. Photo by Sarah Mattison, courtesy of defenseimagery.mil; Photo courtesy of the South African Journal of HIV Medicine. Vol. 9(4), 2008; Laboratory analysis of serum samples in Nigeria. Photo by Maybel Aworh, courtesy of CDC; Woman working in a community garden in Uganda. Photo courtesy of Sean Sprague, CARITAS, under Creative Commons licensing; Mother and baby—Makueni Camp, Kenya. Photo courtesy of Women and Health Alliance International; Protecting Livestock in Kenya. Photo by David Mutua, USAID. ACRONYMS AAA Accra Agenda for Action ASA African Science Academies AEO African Economic Outlook AfDB African Development Bank AGF African Guarantee Fund AGI Association of Ghana Industries ALSF African Legal Support Facility APP African Progress Panel APRM African Peer Review Mechanism AU African Union AVMA American Veterinary Medical Association BVI British Virgin Islands CSO civil society organization DD Demographic Dividend DFI Development Finance Institution DRC Democratic Republic of the Congo ECA Economic Commission for Africa EIA Energy Information Administration EITI Extractive Industries Transparency Initiative ECEFA European Commission for Economic and Financial Affairs FAO Food and Agriculture Organization FDI foreign direct investment FEM foreign exchange market GDP gross domestic product GEM Global Entrepreneurship Monitor GER gross enrolment ratio GPI gender parity index HDI Human Development Index ICB Isoko Community Bank ICT information and communication
    [Show full text]
  • WHO Malaria Elimination Oversight Committee (MEOC) Focused Review Meeting
    Malaria Policy Advisory Committee Meeting 10–12 April 2019, Geneva, Switzerland Background document for Session 8 WHO Malaria Elimination Oversight Committee (MEOC) focused review meeting 12–14 February 2019 Geneva, Switzerland Summary The third meeting of the Malaria Elimination Oversight Committee (MEOC) was held in Geneva on 12– 14 February 2019. Seven countries (Belize, Bhutan, Cabo Verde, Costa Rica, Malaysia, Suriname and Timor-Leste) considered on track for elimination by 2020 were invited for focused review sessions to examine their programme’s performance and achievements and to identify additional issues that could be addressed to improve effectiveness. All 10 full members of the MEOC attended the meeting, along with the national programme manager of Armenia as an adjunct member representing the certified countries. National malaria programme representatives from six of the seven invited countries attended, along with WHO country, regional and headquarters staff, and fund portfolio managers and monitoring and evaluation officers from the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). Each eliminating country presented on their progress towards elimination and their programme’s activities, successes and challenges. All countries except for Costa Rica reported a reduction in case numbers in 2018 compared to 2017, and two countries (Malaysia and Timor-Leste) reported zero indigenous malaria cases in 2018. The MEOC developed individual country recommendations in collaboration with the national programme managers, WHO and GFATM staff, as well as overarching recommendations to WHO and partners. The MEOC will meet next at the 2019 Global Forum of malaria-eliminating countries in Wuxi, China in June. Overarching recommendations 1. The MEOC recognized the critical importance of GFATM resources in helping many countries to achieve elimination, and made the following observations: a.
    [Show full text]
  • Africa's Evolving Infosystems
    March 2011 Africa’s Evolving Infosystems: A Pathway to Security and Stability by Steven Livingston A RESEARCH PAPER FROM THE AFRICA CENTER FOR STRATEGIC STUDIES The Africa Center for Strategic Studies The Africa Center for Strategic Studies supports the development of U.S. strategic policy toward Africa by providing high-quality academic programs, undertaking policy-relevant research and analysis, and fostering awareness of and open dialogue on U.S. strategic priorities and African security issues. Toward these aims, the Center is committed to building networks of African, American, European, and international military and civilian leaders and articulating African perspectives to U.S. policymakers. Africa’s Evolving Infosystems: A Pathway to Security and Stability by Steven Livingston Africa Center for Strategic Studies Research Paper No. 2 National Defense University Press Washington, D.C. March 2011 Opinions, conclusions, and recommendations expressed or implied within are solely those of the contributors and do not necessarily rep- resent the views of the Defense Department or any other agency of the Federal Government. Cleared for public release; distribution unlimited. Portions of this work may be quoted or reprinted without permis- sion, provided that a standard source credit line is included. NDU Press would appreciate a courtesy copy of reprints or reviews. First printing, March 2011 For additional publications of the Africa Center for Strategic Studies, visit the Center’s Web site at http://africacenter.org. Contents Executive
    [Show full text]
  • April 15Th to 20Th, 2018 Dakar-Senegal
    7th Multilateral Initiative on Malaria Panafrican Conference «Two decades of progress, challenges and perspectives in ending Malaria» DETAILED PROGRAM Centre International CICAD de Conférence Abdou Diouf April 15th to 20th, 2018 www.mim2018.com Dakar-Senegal EDCTP 7th Multilateral Initiative on Malaria Conference 2 7th Multilateral Initiative on Malaria Conference 3 Professor Emeritus, Rose G.F. Leke MIM SECRETARIAT CHAIR On behalf of the Multilateral Initiative in Malaria (MIM), I cordially welcome you to the 7th edition of the MIM-Pan African Malaria Conference. This edition of the MIM-Pan African Malaria Conference is unique for a few reasons. First, we are returning to the birth place of the MIM. Yes, MIM was initiated in Dakar, Senegal in 1997. Secondly, this conference would be graced by the presence of several honorable guests including some of MIM founders. One of whom, Nobel Laureate Dr. Harold E. Varmus, would be delivering a keynote talk. There is so much to look forward to and I encourage you all to seize this opportunity to meet with these honorable guests. Lastly, as you may know, this is a transformational moment for MIM. It’s time to review MIM’s activities to better address current malaria research and control priorities and new funding landscape. Throughout the conference, we would be holding consultative meetings to finalize on MIM’s new organizational structure and priority activities. On Day 4 of the conference, that is Wednesday, April 18, 2018, we would hold the MIM General Assembly. This meeting is open to all delegates and would begin at 4:15pm.
    [Show full text]
  • Infectious Etiologies of Febrile Illnesses in Cameroon
    INFECTIOUS ETIOLOGIES OF FEBRILE ILLNESSES IN CAMEROON A DISSERTATION SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OF HAWAI‘I AT MĀNOA IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN BIOMEDICAL SCIENCES (TROPICAL MEDICINE) MAY 2017 By Kenji Obadia Mfuh DissertatiOn COmmittee: Vivek R. Nerurkar, Chairperson Axel T. Lehrer Diane W. TaylOr Richard Yanagihara Alan R. Katz, External Member ACKNOWLEDGEMENTS I thank GOd almighty for seeing me through this journey. I have experienced your guidance day- by-day. I wOuld like to express my sincere appreciatiOn to my advisOr Dr. Vivek R. Nerurkar, yOu have been a tremendous mentor for me. I would like to thank you for encouraging me, believing in me and for allowing me to grow as a researcher. Similar, prOfOund gratitude gOes tO my cOmmittee members and mentors, Dr. Axel T. Lehrer, Dr. Diane W. TaylOr, Dr. Alan R. Katz, Dr. Richard Yanagihara and Dr. ROse Leke fOr yOur brilliant cOmments and suggestiOns. I wOuld equally like to thank the Directors and Health Care WOrkers of the MarOua regiOnal hospital, CNPS hospital Maroua, Catholic health center Nkolbisson and PMI Nkwen, who suppOrted me in recruiting patients fOr my study. Words cannOt express hOw grateful I am tO the staff and students Of the department Of TrOpical Medicine, Medical Microbiology and PharmacOlogy, University Of Hawaii. It has been such a wonderful intellectual and cultural experience. MAHALO! A special thanks tO my family members, friends, the international Baptist fellowship/ministry and the CamerOOnian cOmmunity in Hawaii for their mOral suppOrt, which incented me to strive towards my gOals.
    [Show full text]
  • Documentation from Session 1 of the April 2021 MPAG Meeting
    Documentation related to Session 1 of the meeting Click on the links below to see the pre reads and presentations Malaria Policy Advisory Group (MPAG) Meeting 13 – 15 April 2021 (CEST time zone) Virtual meeting PROVISIONAL PROGRAMME* Tuesday, 13 April 2021 Session 1 Open 12:00 – 12:05 Welcome by the ADG, UCN Dr Ren Minghui 12:05 – 12:15 Welcome by the Chair, MPAG Dr Dyann Wirth 12:15 – 13:00 Report from the Director, GMP Dr Pedro Alonso 13:00 – 13:30 Partner Perspective, US President’s Malaria Dr Raj Panjabi Initiative 13:30 – 14:00 Rethinking malaria: Background & presentation Dr Rose Leke & For guidance part 1 and presentation part 2 Dr Alastair Robb 14:00 – 14:15 Coffee break Session 2 Open 14:15 – 15:00 Clinical malaria – parasite density thresholds in Dr Jane Cunningham different transmission settings and implications for use of RDTs 15:00 – 15:30 Update on the situation of antimalarial drug Dr Pascal Ringwald For guidance efficacy and resistance in Africa 15:30 – 16:00 Proposed technical consultation to stage Dr Kim Lindblade P. knowlesi along the continuum between zoonosis and human pathogen 16:00 End of day Wednesday, 14 April 2021 Session 3 Open 12:00 – 12:45 HRP2 gene deletions – a focus on horn of Africa Dr Jane Cunningham For decision region 12:45 – 13:30 Proposed technical consultation on urban malaria Dr Abdisalan Noor For guidance 13:30 – 13:45 Coffee break Session 4 Open 13:45 – 14:15 Update on guidance for severe malaria Dr Peter Olumese For decision Documentation related to Session 1 of the meeting Click on the links
    [Show full text]
  • Special Meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis (GCC) on Poliovirus Containment
    Special Meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis (GCC) on Poliovirus Containment Geneva, Switzerland, 23 – 25 October 2017 Page 1 of 15 Table of Contents Abbreviations ................................................................................................................................................ 3 Summary of recommendations .................................................................................................................... 4 Introduction and background ....................................................................................................................... 6 Programme update ....................................................................................................................................... 6 Poliovirus containment – orientation ........................................................................................................... 8 Issues, conclusions and recommendations .................................................................................................. 9 Agenda ........................................................................................................................................................ 12 List of participants ....................................................................................................................................... 15 Page 2 of 15 Abbreviations CAG Containment Advisory Group CC Certificate of Containment CCS Containment Certification Scheme to support
    [Show full text]
  • Women in Science: Inspiring Stories from Africa
    The Network of African Science Academies (NASAC) was established on 13th December 2001 in Nairobi, Kenya and is currently the affiliate Network for InterAcademy Partnership (IAP) in Africa. NASAC is a consortium of merit-based science academies in Africa and aspires to make the “voice of science” heard by policy and decision makers within and outside the continent. NASAC is dedicated to enhancing the capacity of existing national science academies and champions in the cause for creation of new academies where none exist. In 2009, NASAC constituted the Women for Science Working Group (WfS WG), a forum for women scientists in Africa aiming to apply the gender-lens in science and the work of science academies. This was done mainly through sharing experiences and setting the gender-specific priorities for academies. Additionally, the Group also encouraged gender mainstreaming in science curricula in education so as to foster pursuit of scientific-careers by girls in schools. The members also agreed to serve as role models. The NASAC WfS WG has provided immense support to this publication on Inspiring Stories of women scientists in Africa. The publication was made possible through the financial support from IAP-Science aimed at inspiring girls and young women to consider scientific careers as a viable option. The members of the NASAC Women for Science Working Group include: Prof. Rose Leke (Cameroon) — Chair Prof. Romeela Mohee (Mauritius) — Vice-Chair Dr. Pacificah Okemwa (Kenya) — Secretary Prof. Francisca Okeke (Nigeria, AAS) Dr. Aster Tsegaye (Ethiopia) Prof. Isabella Quakyi (Ghana) Prof. Waceke Wanjohi (Kenya) Prof. Josephine Ngaira (Kenya) Prof. Nadifi Sellama (Morocco) Prof.
    [Show full text]
  • Report from the Twentieth Meeting of the Global Commission for Certification of Poliomyelitis Eradication
    Report from the Twentieth Meeting of the Global Commission for Certification of Poliomyelitis Eradication Geneva, Switzerland, 17 — 18 October 2019 Report from the Twentieth Meeting of the GCC, Geneva, Switzerland, 17 – 18 October 2019 0 Members of the Global Commission for Certification of Poliomyelitis Eradication after the signing of the certificate of WPV3 eradication Left to Right: Dr Nobuhiko Okabe, Dr Arlene King, Professor David Salisbury, Professor Rose Leke, Professor Yagoub Al-Mazrou, Professor Mahmudur Rahman Report from the Twentieth Meeting of the GCC, Geneva, Switzerland, 17 – 18 October 1 Abbreviations Containment CAG Containment Advisory Group CC Certificate of Containment CCS Containment Certification Scheme to support GAPIII CP Certificate of Participation CWG Containment Working Group ICC Interim Certificate of Containment GAPIII Global Action Plan for Poliovirus Containment NAC National Authority for Containment PEF Poliovirus-Essential Facility Certification GCC Global Commission for Certification of Poliomyelitis Eradication NCC National Certification Committee RCC Regional Commission for Certification of Poliomyelitis Eradication Viruses and vaccines IPV Inactivated poliomyelitis vaccine OPV Oral poliomyelitis vaccine bOPV Bivalent oral poliomyelitis vaccine containing Sabin type 1 and 3 mOPV2 Monovalent oral poliomyelitis vaccine Sabin type 2 nOPV Novel oral poliomyelitis vaccine PV Poliovirus (PV1 is PV type 1 etc) VDPV Vaccine-derived poliovirus aVDPV Ambiguous vaccine-derived poliovirus cVDPV Circulating vaccine-derived
    [Show full text]